Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin

A Oliva, S Carbonara, V Cianci, M Crapis… - Expert Review of Anti …, 2023 - Taylor & Francis
ABSTRACT Introduction Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) are a
common reason of Emergency Department (ED) access and account for a considerable …

A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection

MW Dunne, S Puttagunta, P Giordano… - Clinical Infectious …, 2016 - academic.oup.com
Background. Acute bacterial skin and skin structure infections (ABSSSIs) are a cause of
significant morbidity and therapy can be a burden to the healthcare system. New antibiotics …

[HTML][HTML] REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI

T Papavramidis, I Gentile, AM Cattelan… - International Journal of …, 2023 - Elsevier
Objectives Acute bacterial skin and skin-structure infections (ABSSSIs) are a common
source of morbidity in both the community and hospital settings. The current standard of care …

Dalbavancin use in the emergency department setting

M Patel, S Smalley, Y Dubrovskaya… - Annals of …, 2019 - journals.sagepub.com
Background: Although dalbavancin's (DBV's) long half-life and one-time dosing strategy
confer ideal administration in the ambulatory setting, the optimal role of DBV in the …

Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: A systematic review and meta-analysis

N Monteagudo-Martínez… - Expert Review of Anti …, 2022 - Taylor & Francis
Objectives To know the efficacy of different doses of dalbavancin in acute bacterial skin and
skin-structure infections (ABSSSIs) and versus other antibiotics. Methods We performed a …

[HTML][HTML] Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections

U Rappo, PL Gonzalez, S Puttagunta… - Journal of Global …, 2019 - Elsevier
Objectives Treatment of acute bacterial skin and skin structure infections (ABSSSIs) in the
outpatient setting has potential advantages. We performed a subanalysis of outcomes for …

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

KD Leuthner, KA Buechler, D Kogan… - … and clinical risk …, 2016 - Taylor & Francis
Acute bacterial skin and skin structure infections (ABSSSI) are a common disease causing
patients to seek treatment through the health care system. With the continued increase of …

The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)

A Soriano, GM Rossolini, F Pea - Expert Review of Anti-Infective …, 2020 - Taylor & Francis
Introduction: Acute bacterial skin and skin-structure infections (ABSSSIs) are a subgroup of
skin and soft tissue infections and are a common source of morbidity in both the community …

Cost-consequence analysis of single-dose dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections in a multisite …

J Gonzalez, DC Andrade, JL Niu - Clinical Infectious Diseases, 2021 - academic.oup.com
Background Acute bacterial skin and skin structure infections (ABSSSIs) are common
infectious diseases that cause a significant economic burden on the healthcare system. This …

Real world utilization of Dalbavancin at a rural community emergency department

A Dolan, E Kuge, E Bremmer, T Dietrich… - The American Journal of …, 2022 - Elsevier
Introduction Acute bacterial skin and skin structure infections (ABSSI) are frequently
encountered in the emergency department and compromise more than 700,000 hospital …